Trending in the right direction
Need to know:
- Small earnings and dividend beat
- QBE lifts guidance for FY22 insurance premium growth to 10%
- Improving macro backdrop expected to lift QBE earnings from here
Investment implications:
Result Summary: Small earnings beat (noting the market has been heavily downgrading QBE estimates this year) with a stronger than expected dividend. Guidance upgrades for premium growth are largely reflected in market estimates. Earnings growth is more reliant on rising yields vs insurance earnings growth.
Earnings: Reported NPAT $151m vs market $123m, Cash $169m vs market at $150m, EPS 11cps vs 10cps market. Dividend 9cps vs market 8cps.
Guidance for FY22: QBE is looking for insurance premium growth of “around 10%” vs “high single digit range”. This is largely reflected in market estimates (9.5%), and reflective of a strong global insurance backdrop. This may prove conservative given recent US peer results.
Overall: The market will breathe of sigh of relief on earnings given the large market downgrades on QBE this year. No new “QBE issues” for investors to worry about, will also be well received.
Looking forward the operating environment should lead to muchimproved profitability for QBE into FY23E. We continue to rate QBE a Buy.
FIGURE 1: QBE INSURANCE PREMIUM GROWTH EXPECTED TO LIFT TO ~10% OVER 2022
Stock overview
Share Price
Company overview
QBE is an Australia-based insurance and reinsurance company. QBE underwrites general insurance and reinsurance risks, management of Lloyd's syndicates, and investment management. By revenue, QBE is one of the Top 20 global insurers/reinsurers.
Disclaimers and Disclosures
Issuer
The information and opinions contained within Sandstone Insights Research were prepared by MST Financial Services Pty Ltd (ABN 54 617 475 180, AFSL 500557) ("MST").
Reliance
Whilst MST make every effort to use reliable, comprehensive information in the construction of its reports, MST make no representation, warranty or undertaking of the accuracy, timeliness or completeness of information in this report. Save for any statutory liability that cannot be excluded, MST and MST employees, representative and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person.
General Advice
Any advice contained within Sandstone Insights Research is general advice only and has been prepared without taking into account any person’s objectives, financial situation or needs. Any person, before acting on any advice contained within Sandstone Insights Research, should first consider consulting with a financial adviser to assess whether that advice is appropriate for their objectives, financial situation and needs.
General Disclosures
This report should be read in conjunction with MST Disclaimers and Disclosures and is published in accordance with MST Conflict Management Policy which are available on the MST website: https://www.sandstoneinsights.com.au.
Currency of Research
The recommendations made in a Sandstone Insights Research report are current as of the publication date. If you are reading a report materially after publication, it is likely that circumstances will have changed and at least some aspects of the analysis may no longer hold.
Access and Use
Any access to or use of Sandstone Insights Research is subject to the Terms of Use. By accessing or using Sandstone Insights Research you hereby agree to be bound by our Terms and Conditions and hereby liable for any monies due in payment of accessing this service. In addition you consent to us collecting and using your personal data (including cookies) in accordance with MST Privacy Policy, including for the purpose of a) setting your preferences and b) collecting readership data so MST may deliver an improved and personalised service to you. If you do not agree to MST Terms of Use and/or if you do not wish to consent to MST use of your personal data, please do not access this service.
Equities Research Methodology
Please click here for information about MST equities research methodology.